search
Back to results

Marijuana for Cancer Pain

Primary Purpose

Neoplasms

Status
Terminated
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
Smoked Marijuana
Sponsored by
Center for Medicinal Cannabis Research
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Neoplasms focused on measuring Cancer pain, All types of cancer except lung cancer

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

INCLUSION CRITERIA Have ongoing cancer pain Be diagnosed with cancer and have at least a six month survival. Be on a stable dose of opioid medication for at least 2 weeks before enrollment. Have smoked marijuana on at least 6 occasions in their lifetime prior to enrollment. EXCLUSION CRITERIA You must not: Start chemotherapy, radiation or biphosphonates during the study, or have received any new intervention with any such agents within the past 4 weeks. Currently be using smoked tobacco products. Currently be in methadone treatment. Have smoked marijuana within 30 days of enrollment. Be diagnosed with diabetes mellitus. Have severe heart disease, uncontrolled hypertension, or lung disease. Currently be receiving treatment with corticosteroids. Be pregnant or breastfeeding.

Sites / Locations

  • University of California, San Francisco

Outcomes

Primary Outcome Measures

Change in level of cancer pain as recorded on a 100mm Visual Analog Scale.

Secondary Outcome Measures

Change in level of experimentally induced pain on a 100mm Visual Analog Scale.
Change in nausea and emesis in participants exhibiting these symptoms.
Change in disposition kinetics of opioid analgesics.

Full Information

First Posted
October 1, 2002
Last Updated
October 9, 2013
Sponsor
Center for Medicinal Cannabis Research
Collaborators
University of California, San Francisco
search

1. Study Identification

Unique Protocol Identification Number
NCT00046709
Brief Title
Marijuana for Cancer Pain
Official Title
Marijuana in Combination With Opioids for Cancer Pain: A Pilot Study
Study Type
Interventional

2. Study Status

Record Verification Date
October 2013
Overall Recruitment Status
Terminated
Why Stopped
Discontinued due to non-enrollment.
Study Start Date
September 2002 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
October 2004 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Center for Medicinal Cannabis Research
Collaborators
University of California, San Francisco

4. Oversight

5. Study Description

Brief Summary
To find out if it is safe and effective to use smoked marijuana in combination with opioids to treat cancer pain. The study will evaluate whether smoked marijuana, when used with opioids, will have an effect on pain relief, and to see if marijuana reduces the side effects of opioids, which include nausea and/or vomiting.
Detailed Description
To take part in this study, you must have ongoing cancer pain which is currently being treated with opioids. If you meet all the eligibility criteria you will be admitted to the General Clinical Research Center at San Francisco General Hospital for 9 days. The treatment consists of smoking one marijuana cigarette 3 times a day.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Neoplasms
Keywords
Cancer pain, All types of cancer except lung cancer

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 1, Phase 2
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
16 (false)

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
Smoked Marijuana
Primary Outcome Measure Information:
Title
Change in level of cancer pain as recorded on a 100mm Visual Analog Scale.
Secondary Outcome Measure Information:
Title
Change in level of experimentally induced pain on a 100mm Visual Analog Scale.
Title
Change in nausea and emesis in participants exhibiting these symptoms.
Title
Change in disposition kinetics of opioid analgesics.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
INCLUSION CRITERIA Have ongoing cancer pain Be diagnosed with cancer and have at least a six month survival. Be on a stable dose of opioid medication for at least 2 weeks before enrollment. Have smoked marijuana on at least 6 occasions in their lifetime prior to enrollment. EXCLUSION CRITERIA You must not: Start chemotherapy, radiation or biphosphonates during the study, or have received any new intervention with any such agents within the past 4 weeks. Currently be using smoked tobacco products. Currently be in methadone treatment. Have smoked marijuana within 30 days of enrollment. Be diagnosed with diabetes mellitus. Have severe heart disease, uncontrolled hypertension, or lung disease. Currently be receiving treatment with corticosteroids. Be pregnant or breastfeeding.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Donald I Abrams, M.D.
Organizational Affiliation
UCSF Community Consortium
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of California, San Francisco
City
San Francisco
State/Province
California
ZIP/Postal Code
94110
Country
United States

12. IPD Sharing Statement

Links:
URL
http://cmcr.ucsd.edu
Description
Center for Medicinal Cannabis Research

Learn more about this trial

Marijuana for Cancer Pain

We'll reach out to this number within 24 hrs